Plasma BNP may serve as a useful biomarker for hypertensive left ventricular hypertrophy, though its full pathophysiological significance requires further study.
No takes yet. Share an insight, caveat, or question.
May support BNP for LVH risk stratification in hypertension; leaves open prospective validation before clinical adoption.
Takeda et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: